期刊文献+

血压变异对急性脑梗死静脉溶栓患者出血转化的影响 被引量:12

原文传递
导出
摘要 目的回顾性地分析急性脑梗死患者早期静脉尿激酶溶栓24 h内血压变异对出血转化的影响。方法 2007年6月至2012年12月共有62例急性脑梗死患者应用尿激酶早期静脉溶栓患者入选,溶栓后24 h内监测BP,并于24 h、72 h、7 d分别复查头颅CT,按是否发生脑出血,分为no-HT组(54例,87.1%)和HT组(8例,12.9%)。组间比较采用t或χ2检验,将与溶栓后引起HT相关的参数(P<0.05)进行多因素Logistic回归分析。结果多因素Logistic回归分析显示,房颤(r=1.35,P<0.01)、溶栓前NIHSS评分(r=1.1,P<0.01)及SBPsv(r=1.95,P<0.001)、SBPsvmax(r=2.23,P<0.001)、DBPsv(r=2.44,P<0.001)及DBPsvmax(r=3.30,P<0.001)与溶栓后出血转化密切相关。结论血压变异与急性脑梗死静脉溶栓出血转化的发生密切相关,维持有效灌注压的关键因素之一是维持稳定的血压。
出处 《中华临床医师杂志(电子版)》 CAS 2013年第12期167-169,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献1

二级参考文献8

  • 1TheNationalInstituteofNeurologicalDisordersandStrokertPAStrokeStudyGroup.Tissueplasminogenactivatorforacuteischemicstroke[].NEngJMed.1995
  • 2MulticenterAcuteStrokeTrialItaly(MAST I)Group.Randomisedcontrolledtrialofstreptokinase,aspirinandcombinationofbothintreatmentofacuteischemicstroke[].The Lancet.1995
  • 3Hacke W,Bluhmki E,Steiner T,et al.Dichotomized efficacy end points and global end-point analysis applied to the ECASS in tention-totreat data set.Post hoc analysis of ECASS Ⅰ[].Stroke.1998
  • 4Memezawa H,Simith ML,Siesjo BK.Penumbral tissue salvaged byreperfusion following middle cerebral artery occlusion in rats[].Stroke.1992
  • 5Overgarrd K,Sereghy T,Boysell G,et al.Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model[].Scandinavian Journal of Clinical and Laboratory Investigation.1993
  • 6Del Zoppo GJ,Pessin MS,Mori E,et al.Thrombolytic intervention in acute thrombolic and embolic stroke[].Seminars in Neurology.1991
  • 7The ECASS Study Group.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute he mispheric stroke[].The Journal of The American Medical Association.1995
  • 8Hantson L,Deweerdt W,De keyser J,et al.The European Stroke Scale[].Stroke.1994

共引文献371

同被引文献114

  • 1高艳玲,赵世刚.心源性脑栓塞的临床分析及临床防治[J].医学信息(医学与计算机应用),2014,0(12):661-661. 被引量:1
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 3无.中国脑血管病防治指南(节选)[J].中国现代神经疾病杂志,2007,7(3):217-217. 被引量:50
  • 4JIN X, LIU J, LIU W. Early ischemic blood brain barrier dam- age: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis? [ Jl. Curt" Neu- rovasc Res, 2014, 30(2): 78-82.
  • 5WON S, LEE J H, WALl B, et al. Progesterone attenuates hem- orrhagic transformation after delayed tPA treatment in an experi- mental model of stroke in rats: involvement of the VEGF - MMP pathway[J].J Cereb Blood Flow Metab, 2014, 34( 1 ) : 72 -80.
  • 6KIM B J, LEE S H. Cerebral microbleeds: their associated fac- tors, radiologic findings, and clinical implications[ J]. J Stroke, 2013, 15(3) : 153 -163.
  • 7MESEGUER E, MAZIGHI M, LAPERGUE B, et al. Outcomes after thrombolysis in AIS according to prior statin use: a registry and review[ J]. Neurology, 2012, 79(17) : 1817 - 1823.
  • 8ENGELTER S T, SOINNE L, RINGLEB P, et al. 1V thrombolysis and statins[J]. Neurology, 2011, 77(9): 888-895.
  • 9CAPPELLARI M, DELUCA C, TINAZZ! M, et al. Does statin in the acute phase of ischemic stroke improve outcome after intrave- nous thrombolysis? A retrospective study[J]. J Neurol Sci, 2011, 308(2) : 128 -134.
  • 10SHIMAMURA N, OHKUMA H. Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemor- rhage[J]. Transl Stroke Res, 2014, 5(3): 357-364.

引证文献12

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部